Quest Diagnostics has received an Emergency Use Authorization (EUA) from the FDA for its coronavirus self-collection test kit.
The kit includes a nasal swab to gather a specimen at home or in a healthcare setting. The specimen is then shipped overnight at room temperature for testing. Results are delivered through a patient portal and a mobile app.
Specimens collected using the kit are analyzed on the company’s SARS-CoV-2 RT-PCR test, which received an EUA in March.